WASHINGTON, DC - MAY 12: U.S. Secret Service Director Sean Curran leaves the weekly Republican Senate policy luncheon at the U.S. Capitol on May 12, 2026 in Washington, DC. Curran was on Capitol Hill to brief senators about the request for $1 billion in security funding for President Donald Trump's proposed White House ballroom. (Photo by Chip Somodevilla/Getty Images)

FBI Director Kash Patel testifies during a Senate Committee on Appropriations, Subcommittee on Commerce, Justice, Science and Related Agencies hearing to examine the 2027 budget for law enforcement agencies on Capitol Hill in Washington, DC, on May 12, 2026. (Photo by Jim WATSON / AFP via Getty Images)

FBI Director Kash Patel testifies during a Senate Committee on Appropriations, Subcommittee on Commerce, Justice, Science and Related Agencies hearing to examine the 2027 budget for law enforcement agencies on Capitol Hill in Washington, DC, on May 12, 2026. (Photo by Jim WATSON / AFP via Getty Images)

(FILES) (L/R) US Secretary of Health and Human Services Robert F. Kennedy Jr., Food and Drug Administration (FDA) Commissioner Martin Makary and President Donald Trump attend an announcement event on prescription drugs in the Oval Office of the White House in Washington, DC, on September 30, 2025. President Donald Trump said on May 12, 2026, his US Food and Drug Administration chief, Marty Makary, is leaving his post, a departure that follows weeks of political tumult at the powerful agency. During his tenure atop the sprawling body responsible for overseeing vaccines, medicine and food, Makary managed to upset figures across industry, politics and public health over a range of issues, and most recently faced pressure from the Republican president to sign off on fruit-flavored vapes. (Photo by Brendan SMIALOWSKI / AFP via Getty Images)

(FILES) (L/R) Food and Drug Administration (FDA) Commissioner Martin Makary speaks alongside US Secretary of Health and Human Services Robert F. Kennedy Jr. during the daily briefing in the Brady Briefing Room of the White House in Washington, DC, on January 7, 2026. President Donald Trump said on May 12, 2026, his US Food and Drug Administration chief, Marty Makary, is leaving his post, a departure that follows weeks of political tumult at the powerful agency. During his tenure atop the sprawling body responsible for overseeing vaccines, medicine and food, Makary managed to upset figures across industry, politics and public health over a range of issues, and most recently faced pressure from the Republican president to sign off on fruit-flavored vapes. (Photo by Mandel NGAN / AFP via Getty Images)

(FILES) FDA Commissioner Marty Makary (2L) speaks before US President Donald Trump signs an executive order in the Oval Office of the White House in Washington, DC on April 18, 2026. President Donald Trump said on May 12, 2026, his US Food and Drug Administration chief, Marty Makary, is leaving his post, a departure that follows weeks of political tumult at the powerful agency. During his tenure atop the sprawling body responsible for overseeing vaccines, medicine and food, Makary managed to upset figures across industry, politics and public health over a range of issues, and most recently faced pressure from the Republican president to sign off on fruit-flavored vapes. (Photo by Jim WATSON / AFP via Getty Images)

(FILES) (L/R) Food and Drug Administration (FDA) Commissioner Martin Makary and US President Donald Trump look on during an event about autism in the Roosevelt Room of the White House in Washington, DC on September 22, 2025. President Donald Trump said on May 12, 2026, his US Food and Drug Administration chief, Marty Makary, is leaving his post, a departure that follows weeks of political tumult at the powerful agency. During his tenure atop the sprawling body responsible for overseeing vaccines, medicine and food, Makary managed to upset figures across industry, politics and public health over a range of issues, and most recently faced pressure from the Republican president to sign off on fruit-flavored vapes. (Photo by SAUL LOEB / AFP via Getty Images)

(FILES) US Food and Drug Administration (FDA) Commissioner Martin Makary testifies at an Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Subcommittee hearing on "A Review of the President's FY2026 Budget Request for the Food and Drug Administration" on Capitol Hill in Washington, DC, on May 22, 2025. President Donald Trump said on May 12, 2026, his US Food and Drug Administration chief, Marty Makary, is leaving his post, a departure that follows weeks of political tumult at the powerful agency. During his tenure atop the sprawling body responsible for overseeing vaccines, medicine and food, Makary managed to upset figures across industry, politics and public health over a range of issues, and most recently faced pressure from the Republican president to sign off on fruit-flavored vapes. (Photo by Drew ANGERER / AFP via Getty Images)